Shwetha Asha
About Shwetha Asha
Shwetha Asha is the Medical Director at Alkermes with extensive experience in pharmacovigilance and drug safety, particularly in oncology and rare diseases.
Current Role at Alkermes
Shwetha Asha currently holds the position of Medical Director at Alkermes. In this role, she is responsible for overseeing medical and clinical projects, guiding safety operations, and ensuring compliance with regulatory requirements. Her responsibilities likely include contributing to strategic decision-making processes and collaborating with cross-functional teams to drive the success of various clinical programs.
Previous Experience at QED Therapeutics
From 2020 to 2021, Shwetha Asha served as Associate Medical Director at QED Therapeutics in the San Francisco Bay Area. During her one-year tenure, she was involved in overseeing the safety and efficacy of clinical trials, particularly in the development of oncology medications. Her role required significant interaction with various stakeholders to optimize patient safety and clinical outcomes.
Career at Ultragenyx Pharmaceutical Inc.
Shwetha Asha held multiple roles at Ultragenyx Pharmaceutical Inc. Between 2017 and 2020, she served as a Drug Safety Physician and later as Manager of Drug Safety and Pharmacovigilance. Located in Brisbane, California, her responsibilities included managing the safety aspects of drug trials and ensuring compliance with regulatory safety standards. She was instrumental in handling safety operations for Phase I-III trials, particularly in the fields of oncology and rare diseases.
Professional Journey at Threshold Pharmaceuticals
From 2014 to 2017, Shwetha Asha was affiliated with Threshold Pharmaceuticals. She began her career there as a Senior Pharmacovigilance Specialist and then became Manager of Drug Safety and Pharmacovigilance. In these roles, based in South San Francisco, California, she was responsible for tracking adverse events, ensuring patient safety, and managing pharmacovigilance databases. Her work significantly contributed to the safety management processes of the company’s clinical trials.
Educational Background at Rajiv Gandhi University of Health Sciences
Shwetha Asha completed her MBBS degree at Rajiv Gandhi University of Health Sciences from 2001 to 2007. This rigorous six-year program provided her with a comprehensive education in medicine, laying the foundation for her extensive career in pharmacovigilance and drug safety. Her medical education is complemented by her PUC in Science from AVS, achieved between 1999 and 2001.